Welcome to Paid Research Studies




  • Condition:   Irritable Bowel Syndrome With Constipation
    Interventions:   Drug: SYN-010 21 mg;   Drug: SYN-010 42 mg;   Drug: Placebo
    Sponsors:   Cedars-Sinai Medical Center;   Synthetic Biologics Inc.
    Recruiting

  • Conditions:   Neurofibromatosis Type 1;   Learning Disability;   Reading Disability;   NF1
    Interventions:   Drug: Lovastatin;   Behavioral: reading tutoring intervention;   Drug: Placebo Oral Tablet;   Behavioral: Other Academic "sham" tutoring
    Sponsors:   Vanderbilt University;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting

  • Conditions:   Hyperlipidemia;   Hypercholesterolemia;   Dyslipidemia
    Intervention:  
    Sponsors:   Ohio State University;   National Institute of General Medical Sciences (NIGMS)
    Recruiting

  • Condition:   Hypercholesterolaemia
    Interventions:   Drug: Alirocumab SAR236553 (REGN727);   Drug: Rosuvastatin;   Drug: Atorvastatin;   Drug: Simvastatin;   Drug: Pravastatin;   Drug: Lovastatin;   Drug: Fluvastatin;   Drug: Ezetimibe;   Drug: Cholestyramine;   Drug: Nicotinic acid;   Drug: Fenofibrate;   Drug: Omega-3 fatty acids;   Drug: Placebo
    Sponsors:   Sanofi;   Regeneron Pharmaceuticals
    Recruiting